NASDAQ$HSTM

HealthStream Inc · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

HealthStream reported an increase in revenues, operating income, net income, and EPS for the fourth quarter of 2024 compared to the same period in 2023.

HealthStream announced solid financial results for the fourth quarter of 2024, with revenues increasing by 5.2% to $74.2 million and net income rising by 6.5% to $4.9 million. The company also completed two acquisitions and saw its Learning Center and CredentialStream applications recognized as top software products in healthcare.

  • Revenues for Q4 2024 increased by 5.2% to $74.2 million, up from $70.6 million in Q4 2023.
  • Operating income for Q4 2024 grew by 10.2% to $4.7 million, compared to $4.3 million in Q4 2023.
  • Net income for Q4 2024 was $4.9 million, a 6.5% increase from $4.6 million in Q4 2023.
  • Diluted EPS for Q4 2024 was $0.16 per share, up from $0.15 per share in Q4 2023.

Headline financials

Total Revenue

$74.2M

Previous: $70.6M+5.2%
EPS (adj)

$0.16

Previous: $0.15+6.7%
Adjusted EBITDA

$16.2M

No prior period
Dividend Per Share

$0.03

No prior period
Capital Expenditures

-$26.9M

Previous: -$6.6M-308.2%
Net Income

$4.89M

Previous: $4.6M+6.3%
Operating Income

$4.69M

Previous: $4.3M+9.0%
Gross Profit

$38.7M

Previous: $36M+7.3%
R&D Expense

$12.7M

Previous: $11.9M+6.3%

Revenue & EPS history

HealthStream · Revenue · Quarterly

$74.2M

Q4 2024+5.2%vs Q4 2023
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

HealthStream · $3.1M total across 2 segments · Q3 2023

  • Subscription Revenues
    $3.4M
  • Professional Services
    -$300K

Forward guidance

HealthStream provided financial guidance for the full year 2025, projecting revenues between $302.0 million and $307.0 million, net income between $19.2 million and $21.4 million, and adjusted EBITDA between $70.0 million and $74.0 million.

Tailwinds

  • Projected revenue increase for FY 2025, ranging from $302.0 million to $307.0 million.
  • Anticipated growth in net income for FY 2025, with a range of $19.2 million to $21.4 million.
  • Expected increase in Adjusted EBITDA for FY 2025, projected between $70.0 million and $74.0 million.
  • Guidance assumes continued new sales and renewals.
  • Assumes general economic conditions do not deteriorate.

Headwinds

  • Guidance does not include the impact of any potential acquisitions or dispositions in 2025.
  • Does not account for gains or losses from changes in the fair value of non-marketable equity investments.
  • Does not account for impairment of long-lived assets.
  • The guidance is based on current assumptions and may be affected by unforeseen economic changes.
  • The company undertakes no obligation to update or revise any forward-looking statements.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+0.4%

Avg return

Earnings day

-1.3%

Avg return

5 days after

-0.3%

Avg return

30 days after

49%

32 / 65 earnings

Positive

+22.1%

Q3 2014

Best reaction

-19.3%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.0%-5.2%+3.6%
Q4 2025+5.7%-0.0%+0.0%
Q3 2025+2.8%-2.6%-2.4%
Q1 2025-19.3%-16.2%-14.9%
Q4 2024+0.1%+4.4%-0.8%
Q3 2024+4.3%-1.8%+8.5%
Q2 2024-3.0%-3.4%-7.3%
Q1 2024+6.3%+3.1%+9.8%
Q4 2023-1.6%-2.8%-2.8%
Q3 2023+13.6%+11.0%+16.0%
Q2 2023-1.4%-3.7%-8.1%
Q1 2023-6.9%-9.5%-12.3%
Q4 2022+4.9%+3.1%+7.0%
Q3 2022+4.6%+11.3%+14.3%
Q2 2022+4.5%+2.1%-2.0%
Q1 2022+2.2%-1.6%+4.4%
Q4 2021-17.0%-16.7%-14.7%
Q3 2021-8.8%-6.0%-10.9%
Q2 2021+0.6%-0.8%+0.2%
Q1 2021+9.2%+8.0%+18.4%
Q4 2020+0.7%+0.5%-2.6%
Q3 2020-9.4%-14.2%-9.3%
Q2 2020+0.3%+1.1%-5.6%
Q1 2020-3.4%-9.7%-4.1%
Q4 2019+0.2%+1.4%-16.1%
Q3 2019+6.3%+7.0%+4.4%
Q2 2019-0.8%+3.4%+3.5%
Q1 2019-4.8%-3.0%-5.0%
Q4 2018+3.9%+1.5%+5.8%
Q3 2018+1.8%-5.3%-15.2%
Q2 2018-6.5%-4.2%+6.2%
Q1 2018+4.8%+9.7%+17.3%
Q4 2017+6.0%+2.0%+1.9%
Q3 2017-0.3%-2.7%+2.6%
Q2 2017-12.0%-12.6%-13.5%
Q1 2017+17.3%+17.3%+18.2%
Q4 2016+0.1%+5.0%-2.8%
Q3 2016-9.5%-15.6%-2.3%
Q2 2016-3.9%-6.2%+0.1%
Q1 2016-0.8%
Q4 2015+12.9%
Q3 2015+10.8%
Q2 2015-0.6%
Q1 2015+12.1%
Q4 2014-7.9%
Q3 2014+22.1%
Q2 2014+13.9%
Q1 2014-5.7%
Q4 2013-7.2%
Q3 2013-4.5%
Q2 2013+11.2%
Q1 2013+16.9%
Q4 2012-0.2%
Q3 2012+1.9%
Q2 2012-2.9%
Q1 2011-2.1%
Q1 2012+2.0%
Q4 2009-5.1%
Q4 2011-5.1%
Q3 2010-5.8%
Q3 2011-5.8%
Q2 2011-4.4%
Q2 2010-4.4%
Q4 2010-4.4%
Q1 2010+5.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro